Yahoo Finance 
Typhoid Fever Vaccines Market in the Middle East and Africa 2021-2027, Featuring GlaxoSmithKline plc, Sanofi, Pax Vax Inc and Bharat Biotech
Dublin, March 11, 2021 (GLOBE NEWSWIRE) -- The "Middle East and Africa Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Vaccine Type and Route of administration, and County" report has been added to ResearchAndMarkets.com's offering.
The Middle East and Africa typhoid fever vaccines market is projected to reach US$ 37.09 million in 2027 from US$ 20.00 million in 2019. The market is estimated to grow at CAGR of 8.3% from 2020 to 2027. The report highlights trends prevailing in the Middle East and Africa typhoid fever vaccines market and the factors driving the market along with those that act as hindrances.
The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.
The Middle East and Africa typhoid fever vaccines market is expected to grow owing to growing initiatives for typhoid fever in the Middle East and Africa region. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.
Leading companies operating in the Middle East and Africa typhoid fever vaccines market are includes GlaxoSmithKline plc, Shanghai institute of biological products co., ltd., Sanofi, Pax Vax Inc, Bharat Biotech among others.
Key report benefits:
To understand the Middle East and Africa typhoid fever vaccines market landscape and identify market segments that are most likely to guarantee a strong return.
Stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East and Africa typhoid fever vaccines market.
Efficiently plan M&A and partnership deals in the Middle East and Africa typhoid fever vaccines market by identifying market segments with the most promising probable sales.
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments from the Middle East and Africa typhoid fever vaccines market.
Obtain market revenue forecast for market by various segments from 2019-2027 in the Middle East and Africa.
Key Topics Covered:
1. Introduction
2. Middle East and Africa Typhoid Fever Vaccines Market - Key Takeaways
3. Research Methodology
4. Middle East and Africa Typhoid Fever Vaccines Market Landscape
5. Middle East and Africa Typhoid Fever Vaccines Market Key Market Dynamics
6. Typhoid Fever Vaccines Market - Middle East and Africa Analysis
7. Typhoid Fever Vaccines Market - by Vaccine Type
8. Typhoid Fever Vaccines Market Analysis - by Route of Administration
9. Typhoid Fever Vaccines Market Revenue and Forecasts to 2027 - Geographical Analysis
10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market
11. Company Profiles
GlaxoSmithKline plc
Shanghai institute of biological products co. ltd.
Sanofi
Pax Vax Inc
Bharat Biotech
For more information about this report visit https://www.researchandmarkets.com/r/ph1yel
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
